Nasopharyngeal carcinoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
*[[Nasopharyngeal carcinomas]] account for approximately 70% of all primary malignancies of the [[nasopharynx]], and although it is rare in western populations  
*[[Nasopharyngeal carcinomas]] account for approximately 70% of all primary malignancies of the [[nasopharynx]], and although it is rare in western populations  
*Although it is rare in western populations, it is one of the most common malignancies encountered in Asia, especially China.<ref>http://radiopaedia.org/articles/nasopharyngeal-carcinoma</ref>
*Although it is rare in western populations, it is one of the most common malignancies encountered in Asia, especially China.<ref>http://radiopaedia.org/articles/nasopharyngeal-carcinoma</ref>
It is extremely common in southern regions of China<ref name="pmid18570662">{{cite journal |author=Fang W, Li X, Jiang Q, |title=Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China |journal=J Transl Med |volume=6 |issue= |pages=32 |year=2008 |pmid=18570662 |pmc=2443113 |doi=10.1186/1479-5876-6-32 |url=http://www.translational-medicine.com/content/6//32 }}</ref> (particularly in Guangdong), accounting for 18% of all cancers in China.<ref name="chang2006">{{cite journal |author=Chang E T, Adami H |title=The Enigmatic Epidemiology of Nasopharyngeal Carcinoma |journal=Cancer Epidemiol Biomarkers Prev |volume=15 |issue=10 |pages=1765–1777 |year=2006 |doi=10.1158/1055-9965.EPI-06-0353 |pmid=17035381}}</ref>
*It is extremely common in southern regions of China<ref name="pmid18570662">{{cite journal |author=Fang W, Li X, Jiang Q, |title=Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China |journal=J Transl Med |volume=6 |issue= |pages=32 |year=2008 |pmid=18570662 |pmc=2443113 |doi=10.1186/1479-5876-6-32 |url=http://www.translational-medicine.com/content/6//32 }}</ref> (particularly in Guangdong), accounting for 18% of all cancers in China.<ref name="chang2006">{{cite journal |author=Chang E T, Adami H |title=The Enigmatic Epidemiology of Nasopharyngeal Carcinoma |journal=Cancer Epidemiol Biomarkers Prev |volume=15 |issue=10 |pages=1765–1777 |year=2006 |doi=10.1158/1055-9965.EPI-06-0353 |pmid=17035381}}</ref>


==References==
==References==

Revision as of 12:51, 24 September 2015

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma epidemiology and demographics

CDC on Nasopharyngeal carcinoma epidemiology and demographics

Nasopharyngeal carcinoma epidemiology and demographics in the news

Blogs on Nasopharyngeal carcinoma epidemiology and demographics

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

The prevalence of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in the USA. Patients of all age groups may develop nasopharyngeal carcinoma.

Epidemiology

Age

Patients of all age groups may develop nasopharyngeal carcinoma.

Demographics

  • The prevalence of nasopharyngeal carcinoma is approximately 1 per 100,000 individuals in the USA.[1]
  • Nasopharyngeal carcinomas account for approximately 70% of all primary malignancies of the nasopharynx, and although it is rare in western populations
  • Although it is rare in western populations, it is one of the most common malignancies encountered in Asia, especially China.[2]
  • It is extremely common in southern regions of China[3] (particularly in Guangdong), accounting for 18% of all cancers in China.[4]

References

  1. "Initiative for Vaccine Research (IVR): Viral cancers". World Health Organization. Retrieved 2 October 2012.
  2. http://radiopaedia.org/articles/nasopharyngeal-carcinoma
  3. Fang W, Li X, Jiang Q, (2008). "Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China". J Transl Med. 6: 32. doi:10.1186/1479-5876-6-32. PMC 2443113. PMID 18570662.
  4. Chang E T, Adami H (2006). "The Enigmatic Epidemiology of Nasopharyngeal Carcinoma". Cancer Epidemiol Biomarkers Prev. 15 (10): 1765–1777. doi:10.1158/1055-9965.EPI-06-0353. PMID 17035381.


Template:WikiDoc Sources